Get started
Author

Bernd Lorenz Hartmann

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders
2021 · Christoph Kornauth, Tea Pemovska, et al. · Cancer Discovery · 220
Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
1997 · A Villunger, A Egle, et al. · PubMed · 170
Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts
1999 · David Bernhard, Michael J. Ausserlechner, et al. · The FASEB Journal · 131
PDF
Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line.
1995 · E M Strasser-Wozak, R Hattmannstorfer, et al. · PubMed · 95
Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl‐2, but not by CrmA
1997 · Stephan Geley, Bernd L Hartmann, et al. · FEBS Letters · 73
PDF
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
2013 · G.G. Steger, R. Greil, et al. · Annals of Oncology · 71
PDF
Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
1996 · S Geley, B L Hartmann, et al. · PubMed · 68
Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines
1996 · Monika Hala, Bernd L. Hartmann, et al. · International Journal of Cancer · 67
Increased lactate production follows loss of mitochondrial membrane potential during apoptosis of human leukaemia cells
2001 · Martin Tiefenthaler, Albert Amberger, et al. · British Journal of Haematology · 60
Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients
2021 · Magdalena Benda, Beatrix Mutschlechner, et al. · British Journal of Haematology · 55
PDF
Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosis
1999 · Bernd L Hartmann, Stephan Geley, et al. · Oncogene · 53
Genes mediating glucocorticoid effects and mechanisms of their regulation
1996 · S. Geley, M. Fiegl, et al. · Reviews of physiology, biochemistry and pharmacology · 49
Irradiation induces G2/M cell cycle arrest and apoptosis in p53-deficient lymphoblastic leukemia cells without affecting Bcl-2 and Bax expression
1998 · Elisabeth MC Strasser-Wozak, Bernd L Hartmann, et al. · Cell Death and Differentiation · 46
p53-induced apoptosis in the human T-ALL cell line CCRF-CEM
1997 · Stephan Geley, Bernd L Hartmann, et al. · Oncogene · 42
Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response
2021 · Patrick Reimann, Hanno Ulmer, et al. · British Journal of Haematology · 41
The interleukin 1β‐converting enzyme inhibitor CrmA prevents Apo1/Fas‐ but not glucocorticoid‐induced poly(ADP‐ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells
1997 · Stephan Geley, Bernd L Hartmann, et al. · FEBS Letters · 37
The Cell Cycle Inhibitor p16INK4A Sensitizes Lymphoblastic Leukemia Cells to Apoptosis by Physiologic Glucocorticoid Levels
2001 · Michael J. Ausserlechner, Petra Obexer, et al. · Journal of Biological Chemistry · 36
PDF
A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients
2012 · Alois H Lang, Simone Geller-Rhomberg, et al. · BMC Cancer · 32
PDF
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry
2020 · Florian Huemer, Lukas Weiss, et al. · Journal of Clinical Medicine · 26
PDF
c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblasts
1999 · Markus Löffler, Michael J Ausserlechner, et al. · Oncogene · 26
Interaction between dexamethasone and butyrate in apoptosis induction: non-additive in thymocytes and synergistic in a T cell-derived leukemia cell line
1999 · David Bernhard, Markus Löffler, et al. · Cell Death and Differentiation · 16
Attrition Rates in Multiple Myeloma Treatment under Real World Conditions—An Analysis from the Austrian Myeloma Registry (AMR)
2023 · Magdalena A. Benda, Hanno Ulmer, et al. · Cancers · 11
PDF
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant‐ineligible patients with newly diagnosed multiple myeloma
2024 · Heinz Ludwig, Thomas Melchardt, et al. · American Journal of Hematology · 4
PDF
Carfilzomib-Revlimid-Dexamethasone Vs. Carfilzomib-Thalidomide-Dexamethasone Weekly (After 2 Twice Weekly Cycles) Followed By Carfilzomib Maintenance Vs. Control in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) - Interim Efficacy Analysis of Combined Data (AGMT MM-02)
2019 · Heinz Ludwig, Siegfried Sormann, et al. · Blood · 4
Sequence-specific transcription factors during glucocorticoid-induced apoptosis in acute lymphoblastic leukemia cells.
1999 · B L Hartmann, S Geley, et al. · PubMed · 4
Works count: 62
Citation count: 1,469
H-index: 20
I10-index: 22
Year
Topic
Type